Related Experiment Video
Updated: Aug 3, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Pathophysiology of atherosclerosis: development, regression, restenosis
M R Adams1, S Kinlay, G J Blake
1Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.
Insights
Coronary artery disease patients undergoing angioplasty face challenges with atherosclerosis and restenosis. Integrated management strategies are needed to effectively treat both conditions post-procedure.
Area of Science:
- Cardiology
- Vascular Biology
- Interventional Cardiology
Background:
- A large patient population with coronary artery disease has undergone percutaneous coronary interventions (PCI), including angioplasty.
- Atherosclerosis and restenosis are distinct pathological processes impacting these patients.
- Current clinical practice shows poor application of management strategies targeting both atherosclerosis and restenosis.
Purpose of the Study:
- To highlight the distinct nature of atherosclerosis and restenosis.
- To emphasize the need for improved management strategies in post-PCI patients.
- To advocate for the development of integrated approaches for managing both conditions.
Main Methods:
- This study is a review and synthesis of current understanding of atherosclerosis and restenosis.
- It analyzes the pathophysiologic mechanisms, natural histories, and clinical presentations of both conditions.
- It evaluates existing management strategies and their clinical application.
Main Results:
- Atherosclerosis and restenosis possess different pathophysiologic underpinnings, clinical courses, and treatment requirements.
- Existing management strategies inadequately address both processes concurrently in the post-procedural setting.
- A gap exists in clinical practice regarding the integrated management of these conditions.
Conclusions:
- Effective management of patients with coronary artery disease post-PCI requires addressing both atherosclerosis and restenosis.
- Developing integrated strategies is a critical priority for improving patient outcomes.
- Further research and clinical implementation of combined therapeutic approaches are necessary.
Abstract:
There is now a very large number of patients with coronary artery disease who have also undergone percutaneous interventions such as coronary angioplasty. Atherosclerosis and restenosis are two distinct pathologic processes with different underlying pathophysiologic mechanisms, different natural histories, different clinical presentations, and treatment strategies. Management strategies to target both processes are currently poorly applied in clinical practice. The development of integrated management strategies to target atherosclerosis, as well as restenosis in the postprocedural period remains a priority.
Related Concept Videos
Inflammation
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Peripheral Artery Disease I: Introduction

